Hormone receptor-negative breast cancers such as human epidermal growth factor receptor 2 (HER2)-enriched breast cancer (HER2-enriched BC) and triple-negative breast cancer (TNBC) are known to have higher TIL density than hormone receptor-positive breast cancers [13, 14]. This evidence concerns the gene NR4A1 and breast cancer.